ArticleAntimicrobial agents and chemotherapy2024

BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir.

Wen-Fang Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.